Green Cross Holdings Corporation (KRX:005250)
16,160
+1,240 (8.31%)
Last updated: Jun 5, 2025
Green Cross Holdings Revenue
Green Cross Holdings had revenue of 494.58B KRW in the quarter ending March 31, 2025, with 5.23% growth. This brings the company's revenue in the last twelve months to 2.23T, up 6.69% year-over-year. In the year 2024, Green Cross Holdings had annual revenue of 2.20T with 7.14% growth.
Revenue (ttm)
2,229.43B
Revenue Growth
+6.69%
P/S Ratio
0.33
Revenue / Employee
14.76B
Employees
151
Market Cap
733.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,204.86B | 146.92B | 7.14% |
Dec 31, 2023 | 2,057.94B | -21.62B | -1.04% |
Dec 31, 2022 | 2,079.56B | 239.00B | 12.99% |
Dec 31, 2021 | 1,840.56B | 121.23B | 7.05% |
Dec 31, 2020 | 1,719.33B | 225.74B | 15.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |